Zealand Pharma said a second trial of patients on a higher dosage of its weight-loss drug showed an 8.6% drop in body weight.
More Stories
Southwest Airlines has ‘difficult decisions’ ahead as it works to boost profit, COO says in video message
Southwest Airlines’ chief operating officer has told staff there are “difficult decisions” ahead, as the troubled airline seeks to move...
Tesla’s stock has beaten the S&P 500 lately. Here’s what could drive more gains.
Investors may be expecting a delivery beat this quarter, but such a performance could still help power Tesla shares higher.
Why S&P 500 rising to 6,000 is ‘hardly a stretch’ as stocks attempt new record
The U.S. stock market appears to have “earnings momentum” over the next year, with an S&P 500 price target of...
Cantor Fitzgerald’s Howard Lutnick breaks into interest-rate futures market to challenge behemoth CME
Howard Lutnick, the head of investment bank Cantor Fitzgerald and financial-technology company BGC Group, is breaking into the interest-rate futures...
Nike’s stock falls after analyst’s warning that a ‘negative catalyst’ looms
Nike’s stock fell Monday, after J.P. Morgan warned investors that the athletic apparel and gear giant’s quarterly results could cause...
U.S. business activity suffers small loss of momentum in September, PMI shows
Optimism about the outlook in the year ahead deteriorated sharply to the lowest level since October 2022, in part due...